MBIO - Mustang Bio - Stock Forecast

Healthcare - Sector
Coverage Performance Price Targets & Ratings Chart Insider Trading

MBIO is currently covered by 4 analysts with an average price target of $7.75. This is a potential upside of $6.81 (724.47%) from yesterday's end of day stock price of $0.94.

Mustang Bio's activity chart (see below) currently has 13 price targets and 26 ratings on display. The stock rating distribution of MBIO is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 36% with an average time for these price targets to be met of 163 days.

Highest price target for MBIO is $25, Lowest price target is $8, average price target is $7.75.

Most recent stock forecast was given by JUSTIN ZELIN from BTIG on 15-Nov-2023. First documented stock forecast 21-Dec-2017.

Best performing analysts who are covering MBIO - Mustang Bio:

Mark Breidenbach Joseph Pantginis Kristen Kluska Justin Zelin Mayank Mamtani

Currently out of the existing stock ratings of MBIO, 11 are a BUY (100%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

8

$6.92 (640.74%)

16

4 months 13 days ago

0/5 (0%)

$6.4 (400.00%)

Buy

25

$23.92 (2214.81%)

7

9 months 12 days ago

2/4 (50%)

$17 (212.50%)

24

Buy

1 years 8 months 14 days ago

0/1 (0%)

$70.5 (361.54%)

Buy

8

2 years 4 days ago

4/5 (80%)

$-26.8 (-77.01%)

432

Buy

10

$8.92 (825.93%)

2 years 10 months 16 days ago

1/2 (50%)

$-33.05 (-76.77%)

359

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is MBIO (Mustang Bio) average time for price targets to be met?

On average it took 163 days on average for the stock forecasts to be realized with a an average price target met ratio 36

Which analyst has the current highest performing score on MBIO (Mustang Bio) with a proven track record?

MARK BREIDENBACH

Which analyst has the current lower performing score on MBIO (Mustang Bio) with a proven track record?

MAYANK MAMTANI

Which analyst has the most public recommendations on MBIO (Mustang Bio)?

Mark Breidenbach has 4 price targets and 2 ratings on MBIO

Which analyst is the currently most bullish on MBIO (Mustang Bio)?

Joseph Pantginis with highest potential upside - $23.92

Which analyst is the currently most reserved on MBIO (Mustang Bio)?

Mark Breidenbach with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?